| 摘要 |
FIELD: medicine. ^ SUBSTANCE: what is described is an IL-31 monoclonal antibody. What is offered is a method of treating a mammal suffering an inflammatory disease in which IL-31 in involved that consists in introducing the described antibody. There are offered methods for reducing, inhibiting and minimising itching in a mammal that consist in introducing the described antibody. ^ EFFECT: invention extends the range of anti-inflammatory agents. ^ 39 cl, 4 tbl, 16 ex |
